TikoMed AB   Report issue

For profit Phase 2
Founded: Viken Sweden (2002)

Organization Overview

First Clinical Trial
2018
NCT03613571
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

TikoMed AB

Active Ingredients

Drugs in Phase 2 Trials (2)

dextran sulfate (3 trials)

heparin (liquaemin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Amyotrophic Lateral Sclerosis (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Motor Neuron Disease (Phase 2)

Sclerosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2